Success in a trial of low-intensity ultrasound combined with an amyloid-β antibody represents a major stride towards integrating pharmacological and nonpharmacological approaches to reduce the amyloid-β load in patients with mild Alzheimer disease. This trial also highlights the potential of therapeutic ultrasound modalities to combat neurodegenerative diseases.

中文翻译：

---

超声波和抗体——阿尔茨海默病治疗的潜在强大组合

低强度超声与β-淀粉样蛋白抗体联合试验的成功代表着在整合药物和非药物方法以减少轻度阿尔茨海默病患者的β-淀粉样蛋白负荷方面迈出了一大步。该试验还强调了超声治疗方式对抗神经退行性疾病的潜力。